The etiology and pathogenesis of ulcerative proctitis are complex, and it is not yet possible to completely eradicate the disease.
Ulcerative proctitis belongs to a special type of ulcerative colitis, which has the characteristics of long duration, recurring and prolonged healing, and lacks specific therapeutic measures, and is defined as a modern intractable disease by the World Health Organization.
The main purpose of the current treatment is to induce and maintain symptomatic relief as well as mucosal healing, and to prevent and treat complications. Clinically, appropriate therapeutic drugs are usually selected according to the severity of the patient’s condition and the location of the lesion.
Commonly used drugs include: aminosalicylic acid preparations, such as 5-aminosalicylic acid (5-ASA), which is used for induction of remission and maintenance of mild to moderate ulcerative proctitis; glucocorticosteroids, such as prednisone, which is used for moderate to severe patients who have poor efficacy of 5-ASA; and immunosuppressants, such as azathioprine, which is used for maintenance of patients who have poor efficacy of 5-ASA, recurring symptoms, and hormone dependence.
If you have been diagnosed with ulcerative proctitis, you should seek medical attention as soon as possible and standardize treatment under the guidance of your doctor, depending on the patient’s condition and the stage of the disease.